Records containing: Relapsing Remitting Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics
-
CLINICAL_TRIALS study record update · 2026-04-20The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-15Exploratory Study on the Timing of MS Symptoms
-
CLINICAL_TRIALS study record update · 2026-04-03The Impact of Diet Quality and Calorie Restriction on Physical Function and Patient Reported Outcomes in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-19The Impact of the COVID-19 Pandemic on the Reporting and Management of Multiple Sclerosis Relapses
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-03Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis: A Phase 1b Clinical Trial to Evaluate Feasibility, Safety, Tolerability and Effects on Immune Function
-
CLINICAL_TRIALS study record update · 2026-01-20Study to Evaluate the Usability of Introducing Integrated Digital Solutions Into Clinical Practice and the Value of Their Use in the Medical Care of Patients With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2026-01-06A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)
-
CLINICAL_TRIALS study record update · 2025-12-26Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-10-23A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Study to Evaluate the Safety and Efficacy of Oral PIPE-307 as an Adjunctive Treatment in Subjects With Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-09-30Serum Neurofilaments Light Chain and GFAP (Glial Fibrillary Acidic Protein) in Atypical Idiopathic Inflammatory Demyelinating Disorders
-
CLINICAL_TRIALS study record update · 2025-09-04Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis: A Phase 1b Randomised, Double-blind, Placebo-controlled Trial.
-
CLINICAL_TRIALS study record update · 2025-07-28Danish Non-inferiority Study of Ocrelizumab and Rituximab in MS (DanNORMS): A Randomized Study Comparing the Efficacy of Ocrelizumab and Rituximab in Active Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-07-25Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme
-
CLINICAL_TRIALS study record update · 2025-06-27Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing
-
CLINICAL_TRIALS study record update · 2025-06-02Cladribine Tablets as an Exit Therapy Strategy: Alternative to Continuing Treatment and Plain Treatment Discontinuation in Ageing Stable RMS Patients
-
CLINICAL_TRIALS study record update · 2025-05-31A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-05-16Visual Processing Speed and Objective Analysis of Supranuclear Ocular Movements Control in Multiple Sclerosis Patients and Its Relationship With OCT and Reading Difficulties
-
CLINICAL_TRIALS study record update · 2025-05-02Administration of Fingolimod in Greek Patients With Multiple Sclerosis for the Evaluation of the Efficacy and Safety, Based on the Standard Clinical Practice.
-
CLINICAL_TRIALS study record update · 2025-04-11Assessing Reduced Oligodendrocyte-specific Cytotoxicity of Peripheral Blood Leukocytes in Patients With Multiple Sclerosis Following Treatment With Ofatumumab
-
CLINICAL_TRIALS study record update · 2025-04-04Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics
-
CLINICAL_TRIALS study record update · 2025-03-06A Prospective, Observational Study of Bafiertam Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness in Routine Clinical Practice.
-
CLINICAL_TRIALS study record update · 2025-02-27Evaluating the Potential Role of Melatonin in Subjects With Relapsing Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2025-02-14Serum Neurofilament Light As a Clinical Tool in Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-10-29Rituximab and Ocrelizumab in Serum With Multiple Sclerosis (ROS-MS)